# FDA Inspection 1102672 - Kaiser Permanente Center for Reproductive Health - September 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/kaiser-permanente-center-for-reproductive-health/b7b2b9ef-51fb-44cb-b123-c31c2cec7969
Source feed: FDA_Inspections

> FDA Inspection 1102672 for Kaiser Permanente Center for Reproductive Health on September 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102672
- Company Name: Kaiser Permanente Center for Reproductive Health
- Inspection Date: 2019-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1102672 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-center-for-reproductive-health/49d621c9-ee81-47c8-9851-7d663f461841)
- [FDA Inspection 983869 - 2016-08-17](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-center-for-reproductive-health/405b5568-016e-4d8c-97ba-a86d6ba49c33)
- [FDA Inspection 854836 - 2013-10-29](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-center-for-reproductive-health/0a43dde7-3f68-4c68-a079-443c1ba53ed0)
- [FDA Inspection 751330 - 2011-10-26](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-center-for-reproductive-health/9f05fd6d-9753-4f73-a070-6bdcd5338002)

Company: https://www.keypedia.com/companies/kaiser-permanente-center-for-reproductive-health/b8e4939a-5e0c-4877-aa93-635fc585b59f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d